ESC 365 - Copeptin - a marker of short- and long-term mortality in patients with ST-segment elevation myocardial infarction

ESC Premium Access

Copeptin - a marker of short- and long-term mortality in patients with ST-segment elevation myocardial infarction

Session: Poster session 2 - Adverse outcome in patients with cardiometabolic disorders

Topic: Biomarkers

Speaker: Doctor A. Falkentoft (Roskilde, DK)

Event: ESC Congress 2017

Congress Presentation

Add to my library

About the speaker

Doctor Alexander Christian Falkentoft

Zealand University Hospital, Roskilde (Denmark)

1 presentation

0 follower

14 more presentations in this session

Type 2 diabetes, chronic kidney disease, and mortality in patients with established cardiovascular disease

Speaker: Professor C. Saely (Feldkirch, AT)

Suboptimal management of cardiovascular risk among people with atrial fibrillation - an opportunity for improvement?

Speaker: Associate Professor K. Poppe (Auckland, NZ)

Evaluation of risk factors for major bleeding in AF patients with oral anticoagulation: The Fushimi AF Registry

Speaker: Doctor M. Ishii (Kyoto, JP)

Impact of nutritional and inflammatory status on cardiovascular outcomes in patients with stable coronary artery disease

Speaker: Doctor A. Kunimura (Kobe, JP)

Validation of the European Society of Cardiology non-cardiac surgery risk score in patients with ischemic heart disease

Speaker: Miss K. Norderud (Aarhus C, DK)

Access the full session

Poster session 2 - Adverse outcome in patients with cardiometabolic disorders

Speakers: Doctor A. Falkentoft, Professor C. Saely, Associate Professor K. Poppe, Doctor M. Ishii, Doctor A. Kunimura...

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources